Overview

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates whether Helicobacter pylori eradication improves precancerous lesions including glandular atrophy and intestinal metaplasia as well as metachronous cancers or dysplasias after endoscopic mucosal resection for gastric cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Center, Korea
Treatments:
Amoxicillin
Clarithromycin
Omeprazole
Proton Pump Inhibitors
Rabeprazole